98%
921
2 minutes
20
Lung dynamic hyperinflation (DH) is one of the main determinants of dyspnea in chronic respiratory disease patients. Producing evidence of DH is critical during dyspnea assessment, the objectives being to explain the cause, to target treatments, and to monitor their efficacy. The gold standard method consists in repeated measurement of inspiratory capacity (IC) during cardiopulmonary exercise testing (CPET). Unfortunately, access to CPET is limited and assessment of IC during CPET can be challenging in some patients. An alternative method consists in assessment of IC during the testing known as metronome-paced tachypnea (MPT) challenge. This method is feasible, repeatable, valid (i.e. corelated with dyspnea patients' activities of daily living), and responsive to treatments. However, while its diagnostic performance is acceptable, it is lacking in specificity. Methodological standardization is detailed in the present review, as are the differences between IC changes in CPET and in MPT. As a means of assessing DH, MPT challenge is not only applicable to patients outside a pulmonary function test laboratory, but also easily affordable to any chest physician equipped with a simple spirometry device. A diagnosis threshold of 11% for IC decrease during MPT challenge can be used, albeit while bearing in mind the possibility of a false positive result. Moreover, assessment of IC variations during MPT can help to monitor a patient's overall evolution and response to treatments.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.rmr.2024.12.005 | DOI Listing |
Biomaterials
August 2025
Fischell Department of Bioengineering, University of Maryland, College Park, USA; Biophysics Program, University of Maryland, College Park, USA. Electronic address:
Lymph nodes are highly specialized immune organs that orchestrate the adaptive immune response. In the lymph nodes, naïve B and T lymphocytes encounter cognate antigens, sparking their activation and response to foreign substances. Lymph nodes grow in response to an immune challenge, at least in part to accommodate increased numbers of infiltrating and proliferating B and T lymphocytes.
View Article and Find Full Text PDFTech Innov Patient Support Radiat Oncol
September 2025
Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Introduction: Prospective studies on reirradiation are limited, with most available data being retrospective, resulting in challenges in standardising protocols, interpreting outcomes, and facilitating informed patient decisions. Advanced radiotherapy planning and delivery have increased treatment possibilities for complex cases, including reirradiation. However, considerable gaps and variability in reirradiation image-guided radiotherapy (IGRT) and treatment delivery exist.
View Article and Find Full Text PDFBMC Cancer
August 2025
Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College, Jiangxi Cancer Institute, Jiangxi Clinical Research Center for Cancer, 519 East Beijing Road, Nanchang, Jiangxi Province, 330029, China.
Background: Cutaneous squamous cell carcinoma (CSCC) is a prevalent skin cancer with aggressive progression that poses significant challenges, especially in metastatic cases. Single-cell DNA sequencing (scDNA-seq) has become an advanced technology for elucidating tumor heterogeneity and clonal evolution. However, comprehensive scDNA-seq studies and tailored mutation panels for CSCC are lacking.
View Article and Find Full Text PDFPLoS One
August 2025
Department of Neurology, Hanamaki General Hospital, Hanamaki, Japan.
Background: Myasthenia Gravis (MG) is an autoimmune disease characterized by the production of autoantibodies against neuromuscular junctions, leading to varying degrees of severity and outcomes among patients. This variability makes clinical evaluation crucial for determining appropriate treatment targets. However, accurately assessing Minimal Manifestation (MM) status is challenging, requiring expertise in MG management.
View Article and Find Full Text PDFEur J Surg Oncol
July 2025
Multidisciplinary Breast Center - Department of Women's, Children's and Public Health Sciences, "A. Gemelli" University Hospital Foundation IRCCS. 00168 Rome, Italy; Department of Translational Medicine and Surgery - Catholic University of the Sacred Heart. 00168 Rome, Italy.
Background: Primary breast sarcomas (PBS) and malignant phyllodes tumors (MPT) represent less than 1 % of breast malignancies. Current evidence relies on heterogeneous retrospective series, resulting in controversial therapeutic approaches. This study aimed to analyze long-term outcomes in a large multicentric cohort treated with consistent strategies.
View Article and Find Full Text PDF